Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
2,921,962
-
Share change
-
-236,719
-
Total reported value
-
$15,775,000
-
Price per share
-
$5.42
-
Number of holders
-
13
-
Value change
-
-$1,285,757
-
Number of buys
-
9
-
Number of sells
-
3
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2015
As of 31 Mar 2015,
Aptose Biosciences Inc. - Common Shares was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,921,962 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, BVF INC/IL, BANK OF MONTREAL /CAN/, BAKER BROS. ADVISORS LP, ROYAL BANK OF CANADA, Weiss Multi-Strategy Advisers LLC, DAFNA Capital Management LLC, Knoll Capital Management, LP, and Tower Research Capital LLC (TRC).
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.